Clinical characteristics and prognosis of very young patients with breast cancer in the southern of China

Chinese Journal of Cancer

Volumn 28, Issue 12, 2009, Pages 71-77

  Yang, Hua ^a   Wang, Si Yu ^a   Ou, Wei ^a   Sun, Hai Bo ^a   Fang, Qin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Breast cancer; Clinical characteristic; Prognosis factor; Very young patient

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; KI 67 ANTIGEN; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

ADULT; AGE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHINA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PREMENOPAUSE; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77955770650     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10230     Document Type: Article

References (35)

1. Colleoni M, Rotmensz N, Robertson C, et al. Very young women (<35 years) with operab le breast cancer: features of disease at presentation [J]. Ann Oncol, 2002,13(2):273-279.
2. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973 -1999 Bethesda, MD [R]. National Cancer Institute, 2002:14-15.
3. Holli K, Isola J. Effect of age on the survival of breast cancer patients [J]. Eur J Cancer, 1997, 33 (3):425-428.
4. Korea Central Cancer Registry, Ministry of Health and Welfare, Republic of Korea 2002 Annual Report of the Korea Central Cancer Registry Seoul, Korea [R]. Korea Central Cancer Registry, 2003: 4-5.
5. Meng J, Lang RG, Fan Y, et al. Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis [J]. Zhonghua Zhong Liu Za Zhi, 2007,29 (4):284-288. [in Chinese]
6. Gao B, Yu JJ, Liang GL, et al. Clinical analysis of 71 young women with breast carcinoma [J]. Clin J Gen Surg, 2002, 17 (11): 684-685. [in Chinese]
7. Nab HW, Hop WC, Crommelin MA, et al. Changes in long term prognosis for breast cancer in a Dutch cancer registry [J]. BMJ, 1994,309(6947):83-86.
8. Yang M T, Rong TH, Huang ZF, et al. Clinical analysis of resectable breast cancer: a report of 6263 cases [J]. Chin J Cancer, 2005,24(3): 327-331.
9. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a world wide popu lation-based stud y (CONCORD) [J]. Lancet Oncol, 2008,9(8): 730-756.
10. Gajdos C, Tartter PI, Bleiweiss IJ, et al. Stage 0 to stage III breast cancer in young women [J]. J Am Coll Surg, 2000,190(5):523-529.
11. Walker RA, Lees E, Webb MB, et al. Breast carcinomas occurring in young women (< 35 years) are different [J]. Br J Cancer, 1996,74 (11): 1796-1800.
12. Vrieling C, Collette L, Fourquet A, et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? [J]. Eur J Cancer, 2003,39(7): 932-944.
13. Kollias J, Elston CW, Ellis IO, et al. Early-onset breast cancer histopathological and prognostic considerations [J]. Br J Cancer, 1997,75 (9): 1318-1323.
14. Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for pa tients with stage I or II breast cancer [J]. J Cli n Oncol, 1994,12(5):888-894.
15. Kim JK, Kwak BS, Lee JS, et al. Do very young Korean breast cancer patients have worse outcomes? [J]. Ann Surg Oncol, 2007,14 (12): 3385-3391.
16. Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression [J]. J Cli n Oncol, 2008,26 (20): 3324-3330.
17. Elkhuizen PH, van de Vijver MJ, Hermans J, et al. Local recurrence after breast-conserving therap y for invasive breast cancer: high incidence in young patients and association with poor survival [J]. Int J Radiat Oncol Biol Phys, 1998,40(4):859-867.
18. Kothari AS, Beechey-Newman N, D'Arrigo C, et al. Breast carcinoma in women age 25 years or less [J]. Cancer, 2002,94(3):606-614.
19. Zhou P, Recht A. Young age and outcome for women with early-stag e invasive breast carcinoma [J]. Cancer, 2004,101 (6): 1264-1274.
20. Aebi S, Gelber S, Castiglione-Gertsch M, et al. Is chemotherapy alone ade quate for young women with oestrogen-receptor-positive breast cancer? [J]. Lancet, 2000,355(9218): 1869-1874.
21. Shannon C, Smith IE. Breast cancer in adolescents and young women [J]. Eur J Cancer, 2003,39(18): 2632-2642.
22. Goldhirsch A, Gelber RD, Yothers G, et al. Adjuvant therapy for very young women with breast cancer: need for tailored treatm ents [J]. J Natl Cancer Inst Monogr, 2001 (30): 44-51.
23. Ortmann O, Cufer T, Dixon JM, et al. Adjuvant endocrine therapy for perimenopausal women with early breast cancer [J]. Breast, 2009,18 (1): 2-7.
24. LHRH-agonists in Early Breast Caner Overview group. Use of luteinising- hormone-releasing horm one agonists as adjuvant treatm ent in premenopa usal patients with hormone-receptor- positive breast cancer: a meta-analysis of individual p atient data from rand omised adjuvant trials [J]. Lancet, 2007, 369 (9574): 1711-1723.
25. Muscolino G, Villani C, Bedini AV, et al. Young age is not an ominous prognostic factor in breast cancer patients [J]. Tumori, 1987,73 (3):233-235.
26. Schmidt RT, Tsangaris TN, Cheek JH. Breast cancer in women under 35 years of a ge [J]. Am J Su rg, 1991, 162(3): 197-201.
27. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting high lights: International Consensus Panel on the Treatm ent of Pri mary Breast Cancer [J]. J Natl Cancer Inst, 1998, 90 (21): 1601-1608.
28. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting high lights: International Consensus Panel on the Treatment of Primary Breast Cancer. Se venth International Conference on Adjuvant Therapy of Primary Breast Cancer [J]. J Clin Oncol, 2001, 19(18):3817-3827.
29. Boyages J, Chua B, Taylor R, et al. Use of the St Gallen classification for patients with node -nega tive breast cancer may lead to overuse of adjuvant chemotherapy [J]. Br J Surg, 2002,89(6):789-796.
30. Kroman N, Jensen MB, Wohlfahrt J, et al. Factors influencing the effect of age on prognosis in breast cancer: po pulation based stud y [J]. BMJ, 2000,320(7233):474-478.
31. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials [J]. J Clin Oncol, 2001, 19(6): 1688-1697.
32. Jobsen JJ, van der Palen J, Ong F, et al. The value of a positive margl n for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only [J]. Int J Radiat Oncol Biol Phys, 2003,57(3): 724-731.
33. Neuschatz AC, Dipetrillo T, Safaii H, et al. Long -term follow-up of a prospective policy of margin-di rected radiation dose escalation in breast- conserving therapy [J]. Cancer, 2003,97(1):30-39.
34. Elkhuizen PH, van Slooten HJ, Clahsen PC, et al. High local recurrence risk after breast-conserving therapy in node-negative premenopa usal breast cancer patients Is greatly reduced by one course of perloperat Ive chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study [J], J Clin Oncol, 2000,18(5): 1075-1083.
35. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with rad ical mastectomy for early breast cancer [J], N Engl J Med, 2002,347 (16): 1227-1232.